BioSig’s PURE EP™ System to be Featured During EPLive 2022
25 mai 2022 09h47 HE
|
BioSig Technologies, Inc.
Westport, CT, May 25, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company advancing electrophysiology workflow by delivering...
BioSig Technologies, Inc. Issues Shareholder Letter with Corporate Update on Recent Achievements
11 mai 2022 08h30 HE
|
BioSig Technologies, Inc.
Westport, CT, May 11, 2022 (GLOBE NEWSWIRE) -- To date, Company's FDA 510(k) cleared PURE EP(TM) system has completed over 2,200 patient cases with 75 physicians at 17 hospitals across the...
BioSig to Present at Heart Rhythm 2022
19 avr. 2022 09h10 HE
|
BioSig Technologies, Inc.
Westport, CT, April 19, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) a medical technology company advancing electrophysiology workflow by delivering...
BioSig to Present at NobleCon18 Capital Markets Conference
07 avr. 2022 08h30 HE
|
BioSig Technologies, Inc.
Westport, CT, April 07, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing...
BioSig Technologies, Inc. Partners with Summit Blue Capital to Provide Equipment Leasing Services
29 mars 2022 10h06 HE
|
BioSig Technologies, Inc.
Westport, CT, March 29, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...
BioSig Announces Closing of Public Offering of Common Stock
23 mars 2022 08h00 HE
|
BioSig Technologies, Inc.
Westport, CT, March 23, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal...
BioSig Technologies, Inc. Announces $3 Million Financing with Family Office
22 mars 2022 08h00 HE
|
BioSig Technologies, Inc.
Westport, CT, March 22, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...
BioSig Technologies, Inc. Appoints John Sieckhaus as Chief Operating Officer
16 mars 2022 09h00 HE
|
BioSig Technologies, Inc.
Westport, CT, March 16, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...
Global Precision Cardiology Industry 2021-2031: Focus on Offering, Sample, Technology, Application, End-user, and Region
28 févr. 2022 06h28 HE
|
Research and Markets
Dublin, Feb. 28, 2022 (GLOBE NEWSWIRE) -- The "Precision Cardiology Market - A Global and Regional Analysis: Focus on Offering, Sample, Technology, Application, End User, and Region - Analysis and...
BioSig Awarded US Patent Claims for its PURE EP™ Noise-Filtering Technology
26 janv. 2022 13h00 HE
|
BioSig Technologies, Inc.
Westport, CT, Jan. 26, 2022 (GLOBE NEWSWIRE) -- Claims address computer-implemented systems and methods for filtering noise from input cardiac signals using its PURE EP™ technologyThe Company now...